| Michele Lisette Larroque, MD | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-3930 | |
| Not Available |
| Full Name | Michele Lisette Larroque |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 22 Years |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063568525 | NPI | - | NPPES |
| 08431790 | Medicaid | MS | |
| 1055557 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD026013 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - Walker Dialysis | Walker, LA | Dialysis facility |
| Davita - Dialysis Systems Of Covington | Covington, LA | Dialysis facility |
| Davita - Essen Lane Dialysis | Baton rouge, LA | Dialysis facility |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.
Dr Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organisation.
› Verified 6 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.
Dr Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organisation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele Lisette Larroque, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-3930 | Michele Lisette Larroque, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-3930 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
Drugs for brain diseases such as Alzheimer's, Parkinson's, and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of non-profit organizations and funders announced today.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.
Dr Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organisation.
› Verified 6 days ago
Leigh Victoria Deshotels, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # Sl50, New Orleans, LA 70112 Phone: -- | |
Dr. James Desporte Lilly, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2820 Napoleon Ave, Suite 720, New Orleans, LA 70115 Phone: 504-896-8670 Fax: 504-896-8699 | |
Carmen Gladys Espinoza, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1542 Tulane Ave, New Orleans, LA 70112 Phone: 504-903-1301 | |
Jose Rodrigo Restrepo, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: Department Of Radiology, 1542 Tulane Ave, Box T2-2, New Orleans, LA 70112 Phone: 504-568-4646 | |
Jorge Alan Martinez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2021 Perdido St, New Orleans, LA 70112 Phone: 504-903-3000 | |
Dr. Princess Eronmwon Dennar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl-16, New Orleans, LA 70112 Phone: 504-988-7518 Fax: 504-988-8252 | |
Eric Edward Holt I, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4747 Earhart Blvd Ste. J, New Orleans, LA 70125 Phone: 504-592-9818 Fax: 504-522-2248 |